ERS International Congress, Milan 2017

---

Obstructive and central sleep apnoea: consequences and comorbidities

Thematic Poster
Chairs: W. Galetke (Dorsten, Germany), J. Verbraecken (Edegem (Antwerp), Belgium), M. Arzt (Regensburg, Germany)

Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances R. Plywaczewski (Warszawa, Poland)
Monocyte count/HDL cholesterol ratio and cardiovascular disease in patients with obstructive sleep apnea syndrome; a multicenter study H. Inönü Köseoglu (TOKAT, Turkey)
Sleep-disordered breathing is related to Metabolic Syndrome in Outpatients with Diabetes Mellitus Type 2 K. Neumann (Regensurg, Germany)
New opportunities for screening of subclinical atherosclerosis in patients with obstructive sleep apnea (OSA) – a pilot study V. Stratev (VARNA, Bulgaria)
Do glaucoma, nonarteritic ischemic anterior optic neuropathy and sleep apnea march hand in hand? M. Ledina (Sokobanja, Republic of Serbia)
Does sleep apnoea cause acute myocardial injury detectable by biomarkers? N. Tröster (Graz, Austria)
Myocardial alterations in asymptomatic patients with obstructive sleep apnea syndrome P. Gudiel Arriaza (Leon, Spain)
Prevalence and contributing factors for daytime and nocturnal hypoxia in chronic heart failure patients R. Tamisier (Grenoble, France)
Effect of vadaptive servo ventilation on mortality in patients with systolic heart failure and central sleep apnea S. Javaheri (Cincinnati, United States of America)
Whom are we treating with adaptive servo-ventilation? - a clinical post-hoc analysis M. Arzt (Regensburg, Germany)
Cheyne-stokes-respiration is an independent modulator of systolic blood pressure in patients with diabetes mellitus type 2 A. Schreib (Regensburg, Germany)
Is acute pulmonary embolism more severe in the presence of obstructive sleep apnoea? Results from a cohort study. T. Berghaus (Augsburg, Germany)
The prevalence of unrecognized obstructive sleep apnea syndrome among patients with nocturnal symptoms and poorly controlled asthma L. Lo (Hong Kong, Hong Kong)
Frequency and characterization of sleep related disorders in interstitial lung disease patients: a prospective study C. Nicoletta (pontecagnano faiano, Italy)
The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease. P. Bielicki (Warszawa, Poland)
Parathyroid Hormone and Vitamin D Levels in Obstructive Sleep Apnea V. Pencheva (Sofia, Bulgaria)
Obstructive sleep apnoea and quality of life in Fabry disease: A parallel cohort study T. Gaisl (Zürich, Switzerland)
Obstructive sleep apnoea and pulmonary involvement in patients with scleroderma T. Yakut (ISTANBUL, Turkey)
Risk for sleep apnea and excessive daytime sleepiness in patients with Myasthenia gravis. E. Oliveira (Sao Paulo, Brazil)
Evaluation of sleep quality and daytime sleepiness in ankylosing spondylitis O. Sengoren Dikis (Van Ercis, Turkey)